Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives
Top Cited Papers
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 56 (4) , 633-654
- https://doi.org/10.1124/pr.56.4.5
Abstract
In the last two decades, there has been a growing interest in unraveling the role that the Na+/Ca2+ exchanger (NCX) plays in the function and regulation of several cellular activities. Molecular biology, electrophysiology, genetically modified mice, and molecular pharmacology have helped to delve deeper and more successfully into the physiological and pathophysiological role of this exchanger. In fact, this nine-transmembrane protein, widely distributed in the brain and in the heart, works in a bidirectional way. Specifically, when it operates in the forward mode of operation, it couples the extrusion of one Ca2+ ion with the influx of three Na+ ions. In contrast, when it operates in the reverse mode of operation, while three Na+ ions are extruded, one Ca2+ enters into the cells. Different isoforms of NCX, named NCX1, NCX2, and NCX3, have been described in the brain, whereas only one, NCX1, has been found in the heart. The hypothesis that NCX can play a relevant role in several pathophysiological conditions, including hypoxia-anoxia, white matter degeneration after spinal cord injury, brain trauma and optical nerve injury, neuronal apoptosis, brain aging, and Alzheimer's disease, stems from the observation that NCX, in parallel with selective ion channels and ATP-dependent pumps, is efficient at maintaining intracellular Ca2+ and Na+ homeostasis. In conclusion, although studies concerning the involvement of NCX in the pathological mechanisms underlying brain injury during neurodegenerative diseases started later than those related to heart disease, the availability of pharmacological agents able to selectively modulate each NCX subtype activity and antiporter mode of operation will provide a better understanding of its pathophysiological role and, consequently, more promising approaches to treat these neurological disorders.This publication has 186 references indexed in Scilit:
- Effects of Antisense Oligonucleotides to the Cardiac Na+/Ca2+ Exchanger on Calcium Dynamics in Cultured Cardiac MyocytesBiochemical and Biophysical Research Communications, 1999
- Localization of an Exchange Inhibitory Peptide (XIP) Binding Site on the Cardiac Sodium-Calcium ExchangerBiochemical and Biophysical Research Communications, 1997
- Role of Na+‐Ca2+ Exchanger in Agonist‐Induced Ca2+ Signaling in Cultured Rat AstrocytesJournal of Neurochemistry, 1996
- A Novel Isothiourea Derivative Selectively Inhibits the Reverse Mode of Na+/Ca2+ Exchange in Cells Expressing NCX1Journal of Biological Chemistry, 1996
- Cytochalasins Protect Hippocampal Neurons Against Amyloid β‐Peptide Toxicity: Evidence that Actin Depolymerization Suppresses Ca2+ InfluxJournal of Neurochemistry, 1995
- Effects of Antisense Oligonucleotides to the Cardiac Na+/Ca2+ Exchanger on Cultured Cardiac MyocytesBiochemical and Biophysical Research Communications, 1995
- The effect of opiate agonists and antagonists on Na+-Ca2+ exchange in cardiac sarcolemma vesiclesLife Sciences, 1992
- Possible involvement of Ca++ ions, protein kinase C and Na+-H+ antiporter in insulin-induced endogenous dopamine release from tuberoinfundibular neuronsLife Sciences, 1990
- Stimulation of heart sarcolemmal Na+-Ca2+ exchange by Concanavalin ABiochemical and Biophysical Research Communications, 1988
- Stimulation of Na+Ca2+ exchange in heart sarcolemma by insulinLife Sciences, 1986